Ask a pathologist by Coberly, Emily & Esebua, Magda
What is the next best step in patient management? 
 
    A)  Obtain electrolytes 
    B)  Administer calcium gluconate 
    C)  Emergent hemodialysis 
    D)  IV magnesium 
 
 
3)  A 55-year-old male with history of congestive heart failure, hypertension and ischemic 
cardiomyopathy is admitted for nausea, vomiting and diarrhea of 2 days duration. EKG was 
obtained and is shown below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What is the most likely cause of the EKG findings? 
  
    A)  Electrolyte imbalance 
    B)  Drug related 
    C)  Myocardial ischemia 
    D)  Pericardial effusion 
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ASK A PATHOLOGIST 
 
Emily Coberly, MD, Magda Esebua, MD 
University of Missouri Health Care 
 
QUESTION:  My patient has a palpable neck mass that is suspicious for malignancy, and I am 
considering ordering a fine needle aspiration (FNA) versus a core needle or open biopsy.  Which type 
of biopsy will have the fastest result from pathology?  
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ANSWER:  Fine Needle Aspiration (FNA) is the most rapid method of obtaining a 
tissue diagnosis.  FNAs are performed manually by pathologists, clinicians or surgeons for the 
assessment of palpable masses, and may also be performed under ultrasound or CT guidance for non-
palpable lesions.  FNA biopsy can be useful in the diagnosis malignancies, certain infections (fungal, 
viral, protozoal), inflammation (granulomas, sarcoidosis) or infiltration (amyloidosis).  The advantages 
of FNA biopsy can be summed up in the acronym SAFE: Simple; Accurate; Fast; Economic. 
 
For palpable lesions, FNA can be performed on an outpatient basis or at the patient’s bedside in the 
hospital. It has the best safety record of any method of procuring tissue for a morphologic diagnosis.   
No other biopsy can be processed as rapidly as an FNA biopsy—open tissue or core needle biopsies 
must be fixed in formalin and embedded in paraffin for several hours and even intra-operative frozen 
sections take several minutes to freeze and stain with H&E.  FNA samples are air-dried and stained 
with Diff Quick stain which requires about one minute, and slides can then be examined wet without a 
cover slip at the time of FNA.  Microscopic evaluation by a pathologist at the time of FNA is referred 
to as Rapid On-Site Evaluation or ROSE, and can be used to confirm that the obtained sample is 
adequate/diagnostic to rapidly triage additional testing that may be needed for that specimen (for 
example, a portion might be sent for flow cytometry if the specimen suggests a lymphoproliferative 
process), and to give the patient and clinician a preliminary diagnosis at the time of FNA. 
 
Risks of FNA include pain and anxiety, hematoma or minor bleeding, vasovagal reaction, nerve damage, 
infection, and tumor necrosis.  The needles used for FNA are usually 23 gauge or smaller, the same or 
smaller than needles used for routine phlebotomy.  Anesthetic is generally not required.  Non-image 
guided FNA should not be performed if the patient has a bleeding disorder, has a skin infection at the 
FNA site, is extremely uncooperative or agitated, or if the mass is not palpable. 
 
Send your questions to coberlye@health.missouri.edu to be  
published in future editions of the Missouri Hospitalist. 
 
ID Corner 
William Salzer, MD 
Professor, Division of Infectious Diseases, University of Missouri Health Care 
 
Laboratory Diagnosis of Infections 
Ever wonder what type of culture or test to order to diagnose an infection? Well, the IDSA has 
published guidelines which are arranged by anatomical site, with lots of tables that tell you what 
culture, Smear, PCR or serologic test to obtain to optimally make a diagnosis of an infection: 
 
Baron EJ et al. A guide to the utilization of the microbiology laboratory for diagnosis of infectious 
diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the 
American Society for Microbiology (ASM). Clin Infect Dis 2013; 57:485.  
 
http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Laboratory%20Diagnosis%20of%20Infectious%
20Diseases%20Guideline.pdf  
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